Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
50 Leser
Artikel bewerten:
(0)

Frost & Sullivan Lauds ZirMed for Driving Future Business Value with its Web-based Revenue Cycle Management Solution for the Healthcare Industry

ZirMed's end-to-end RCM portfolio significantly facilitates healthcare organizations' revenue collection process and expedites return on investment

MOUNTAIN VIEW, California, Oct. 13, 2016 /PRNewswire/ --Based on its recent analysis of the healthcare revenue cycle management (RCM) solutions market, Frost & Sullivan recognizes ZirMed®, Inc. with the 2016 North American Technology Innovation Award. As a leading provider of web-based RCM technology and services, ZirMed maintains an expansive line of solutions. These products help streamline the revenue collection process, enhance patient satisfaction, and accelerate payment collection for healthcare organizations.

Photo - http://photos.prnewswire.com/prnh/20161013/428413

ZirMed's end-to-end product portfolio comprises solutions for patient access, claims management, charge integrity, accounts receivable (AR) management, patient responsibility, and population health management. ZirMed tailors its product portfolio to customers' specific management needs, accelerating return on investment.

ZirMed helps healthcare providers identify the type of patient most likely to need a structured payment plan and checks eligibility and coverage details at the point of care or even before the patient arrives for the appointment. The patient receives his or her paper or electronic statement at a later date, which contains an easy-to-understand breakdown of the bill, including insurance coverage, upfront payment, and outstanding dues.

ZirMed's patient payments portal is compatible with mobile devices, computers, and tablets and provides users with a retail experience. If patients prefer to pay by mail or over the phone, ZirMed offers secure collections and lockbox services to guarantee tracking and accurate reconciliation of cash and paper-check payments.

"ZirMed continuously invests in claims management and electronic data interchange capabilities since pioneering cloud-based medical claims clearinghouse services in 1999," said Frost & Sullivan Principal Analyst, Nancy Fabozzi. "In addition to custom rules and edits, ZirMed assimilates customer feedback to update its rules and develop easy-to-understand edits and rejection messages. As a result, ZirMed delivers a 98%+ first-pass clean claims rate."

When claims are denied, ZirMed's AR management solution identifies, routes, and appeals for recoverable dollars. The solution uncovers billable insurance for patients who may not realize they are covered for specific types of care under secondary commercial or government insurance, to ensure all relevant government and commercial payers reimburse appropriately.

In addition to front-end claims, ZirMed accelerates and streamlines the receiving, processing, and reconciling of payer payments, both electronic and paper. Paper payments can automatically convert to electronic transactions and deposit electronically, and ZirMed tracks and matches all payer payments to associated claims automatically.

Another important component of ZirMed's portfolio is the charge integrity solution powered by predictive analytics. The solution prevents charge-capture leakage, resolves process inefficiencies, improves coding compliance, and maintains the complete integrity of all inpatient and outpatient accounts. The solution enables organizations to work by exception, which is a huge advantage in large healthcare organizations, where the number of claims runs into millions, and individual charges run into tens of millions.

"ZirMed's platform integrates with claims monitoring capabilities, allowing customers to view the status of each claim in the payment process," noted Fabozzi. "If a payment is not made, ZirMed automatically works directly with payers to triage the holdup and collect payment on behalf of its client."

ZirMed's dedication to meeting customer needs has gone a long way in helping the company achieve a year-over-year growth of 30% in 2015. This growth underlines ZirMed's perceived value to its customers, making it richly deserving of Frost & Sullivan's 2016 North American Technology Innovation Award.

Each year, Frost & Sullivan presents this award to the company that has demonstrated uniqueness in developing and leveraging new technologies that significantly impact both the functionality and the customer value of the new products and applications. The award lauds the high research and development (R&D) spending towards innovation, its relevance to the industry, and the positive impact on brand perception.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for outstanding achievement in areas such as leadership, technological innovation, customer service, and product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research.

About ZirMed, Inc.

ZirMed's comprehensive end-to-end platform of cloud-based revenue cycle management solutions-including patient access, charge integrity, claims management, AR management, patient responsibility, and population health management-empowers healthcare organizations of all sizes and types to optimize value-driven and fee-for-service reimbursements. By combining breakthrough predictive analytics technology with innovative software development and the industry's most advanced transactional network, ZirMed solutions extract actionable insights that improve our clients' revenue cycles while streamlining workflows, increasing operating efficiencies, and driving bottom-line results. ZirMed's technology and client support continue to be honored with top industry awards, including KLAS®, Healthcare Informatics, Best of SaaS Showplace (BoSS), and Black Book Rankings. To learn how ZirMed can help your healthcare organization boost its financial performance in an era of changing reimbursement models and rising operating costs, visit ZirMed.com.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion

Join Us: Join our community

Subscribe: Newsletter on "the next big thing"

Register: Gain access to visionary innovation

Contact:
Chiara Carella
P: +44 (0) 207.343.8314
F: 210.348.1003
E: chiara.carella@frost.com

Joy Dinaro
Amendola Communications for ZirMed
P: +1.847.809.0406
E: JDiNaro@ACMarketingPR.com


© 2016 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.